Yunnan Baiyao Group Co.,Ltd (SHE:000538)

Market Cap	100.03B
Revenue (ttm)	40.77B
Net Income (ttm)	5.20B
Shares Out	1.78B
EPS (ttm)	2.92
PE Ratio	19.21
Forward PE	17.21
Dividend	2.20 (3.93%)
Ex-Dividend Date	Sep 24, 2025

Volume	4,296,844
Average Volume	7,504,963
Open	56.08
Previous Close	56.07
Day's Range	56.00 - 56.15
52-Week Range	53.56 - 61.15
Beta	0.47
RSI	43.84
Earnings Date	Oct 31, 2025

About SHE:000538

Yunnan Baiyao Group Co.,Ltd engages in the pharmaceutical business in China. The company offers health products; drugs; chemical raw materials, chemical preparations, sales of chemical raw materials, chemical preparations, Chinese patent medicines, Chinese herbal medicines, biological products, medical devices, health food, food, beverages, special labor protection products, production and sales of daily chemical products, cosmetics and outdoor products; production and sales of rubber plasters, plasters, disinfection products, electronic and di...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1902
• Employees: 9,277
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000538

Financial Performance

In 2024, SHE:000538's revenue was 40.03 billion, an increase of 2.36% compared to the previous year's 39.11 billion. Earnings were 4.75 billion, an increase of 16.02%.